 |
||||
|
||||
|
||||
|
||||
|
||||
The Journal of Neuroscience, September 7, 2005, 25(36):8217-8228; doi:10.1523/JNEUROSCI.1859-05.2005
Previous Article | Next Article
Development/Plasticity/Repair
Neurogenesis and Neuroprotection Induced by Peripheral Immunomodulatory Treatment of Experimental Autoimmune Encephalomyelitis
Rina Aharoni,1 Ruth Arnon,1 andRaya Eilam2 Departments of 1Immunology and 2Veterinary Resources, The Weizmann Institute of Science, Rehovot, 76100 Israel
Brain insults such as the autoimmune inflammatory process in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE) induce a measure of neurogenesis, but its regenerative therapeutic consequence is limited, because it fails to regenerate functional neurons and compensate the damage. Here, we investigated whether peripheral immunomodulatory treatment for MS/EAE, glatiramer acetate (GA), can enhance neurogenesis and generate neuroprotection in the CNS of EAE-inflicted mice. EAE was induced by myelin oligodendrocyte glycoprotein peptide, either in yellow fluorescent protein (YFP) 2.2 transgenic mice, which selectively express YFP on their neuronal population, or in C57BL/6 mice. The in situ effect of GA was studied in various brain regions; neuroprotection and neurogeneration were evaluated and quantified by measuring the expression of different neuronal antigens and in vivo proliferation markers. The results demonstrated that in EAE-inflicted mice, neuroproliferation was initially elevated after disease appearance but subsequently declined below that of naive mice. In contrast, GA treatment in various stages of the disease led to sustained reduction in the neuronal/axonal damage typical to the neurodegenerative disease course. Moreover, three processes characteristic of neurogenesis, namely cell proliferation, migration, and differentiation, were augmented and extended by GA treatment in EAE mice compared with EAE-untreated mice and naive controls. The newborn neuroprogenitors manifested massive migration through exciting and dormant migration pathways, into injury sites in brain regions, which do not normally undergo neurogenesis, and differentiated to mature neuronal phenotype. This suggests a direct linkage between immunomodulation, neurogenesis, and an in situ therapeutic consequence in the CNS.
Key words: neurogenesis; neuroprotection; immunomodulation; multiple sclerosis; MS; experimental autoimmune encephalomyelitis; EAE; glatiramer acetate
Received May 10, 2005; revised July 12, 2005; accepted July 12, 2005.
This article has been cited by other articles:
L. Bernardino, F. Agasse, B. Silva, R. Ferreira, S. Grade, and J. O. Malva
Tumor Necrosis Factor-{alpha} Modulates Survival, Proliferation, and Neuronal Differentiation in Neonatal Subventricular Zone Cell Cultures
Stem Cells, September 1, 2008; 26(9): 2361 - 2371.
[Abstract] [Full Text] [PDF]
R. Aharoni, A. Herschkovitz, R. Eilam, M. Blumberg-Hazan, M. Sela, W. Bruck, and R. Arnon
Demyelination arrest and remyelination induced by glatiramer acetate treatment of experimental autoimmune encephalomyelitis
PNAS, August 12, 2008; 105(32): 11358 - 11363.
[Abstract] [Full Text] [PDF]
R. Baron, A. Nemirovsky, I. Harpaz, H. Cohen, T. Owens, and A. Monsonego
IFN-{gamma} enhances neurogenesis in wild-type mice and in a mouse model of Alzheimer's disease
FASEB J, August 1, 2008; 22(8): 2843 - 2852.
[Abstract] [Full Text] [PDF]
D. Frumkin, A. Wasserstrom, S. Itzkovitz, T. Stern, A. Harmelin, R. Eilam, G. Rechavi, and E. Shapiro
Cell Lineage Analysis of a Mouse Tumor
Cancer Res., July 15, 2008; 68(14): 5924 - 5931.
[Abstract] [Full Text] [PDF]
S. Gorantla, J. Liu, H. Sneller, H. Dou, A. Holguin, L. Smith, T. Ikezu, D. J. Volsky, L. Poluektova, and H. E. Gendelman
Copolymer-1 Induces Adaptive Immune Anti-inflammatory Glial and Neuroprotective Responses in a Murine Model of HIV-1 Encephalitis
J. Immunol., October 1, 2007; 179(7): 4345 - 4356.
[Abstract] [Full Text] [PDF]
J.-Q. Liu, J. W. Carl Jr, P. S. Joshi, A. RayChaudhury, X.-A. Pu, F.-D. Shi, and X.-F. Bai
CD24 on the Resident Cells of the Central Nervous System Enhances Experimental Autoimmune Encephalomyelitis
J. Immunol., May 15, 2007; 178(10): 6227 - 6235.
[Abstract] [Full Text] [PDF]
F. Blanchette
Clinical significance of glatiramer acetate antibodies
Multiple Sclerosis, May 1, 2007; 13(1_suppl): 28 - 35.
[Abstract] [PDF]
P. Sarchielli, M. Zaffaroni, A. Floridi, L. Greco, A. Candeliere, A. Mattioni, S. Tenaglia, M. Di Filippo, and P. Calabresi
Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-{beta} 1a, and high doses of immunoglobulins
Multiple Sclerosis, April 1, 2007; 13(3): 313 - 331.
[Abstract] [PDF]
J. Hallenbeck, G. del Zoppo, T. Jacobs, A. Hakim, S. Goldman, U. Utz, A. Hasan, and for the Immunomodulation Workshop Participants
Immunomodulation Strategies for Preventing Vascular Disease of the Brain and Heart: Workshop Summary
Stroke, December 1, 2006; 37(12): 3035 - 3042.
[Abstract] [Full Text] [PDF]
L. B. J. Morales, K. K. Loo, H.-b. Liu, C. Peterson, S. Tiwari-Woodruff, and R. R. Voskuhl
Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis.
J. Neurosci., June 21, 2006; 26(25): 6823 - 6833.
[Abstract] [Full Text] [PDF]
R. Aharoni, R. Eilam, H. Domev, G. Labunskay, M. Sela, and R. Arnon
The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice
PNAS, December 27, 2005; 102(52): 19045 - 19050.
[Abstract] [Full Text] [PDF]
J. R. Munoz, B. R. Stoutenger, A. P. Robinson, J. L. Spees, and D. J. Prockop
Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice
PNAS, December 13, 2005; 102(50): 18171 - 18176.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|